Vascular Surgery



	Our Physicians:

	Harry L. Bush, Jr., MD

	Rajeev Dayal, MD

	Alexander Gart, MD

	John Karwowski, MD

	Ross T. Lyon, MD

	James F. McKinsey, MD

	Nicholas J Morrissey, MD

	Roman Nowygrod, MD

	Kenneth Ouriel, MD

	Michael Silane, MD

	Shubha Varma, MD

Kenneth Ouriel, MD

Senior Vice President and Chief of International Operations

List of Publications on PubMed

Internationally recognized leader for his experience and leadership in healthcare, Dr. Ouriel joined NewYork-Presbyterian Hospital and the Division of Vascular Surgery in 2008.

Following the completion of training in 1987, Dr. Ouriel went into the academic practice of Vascular Surgery as an Assistant Professor of Surgery at the University of Rochester. He was active both clinically and academically, with a basic research lab funded by an NIH grant on vascular thrombosis. He was promoted to Associate Professor of Surgery in 1992. He led a multicenter study on thrombolysis for acute lower extremity arterial occlusion, published in the New England Journal of Medicine in 1998. He was recruited to the Cleveland Clinic that year to lead its Department of Vascular Surgery and held the academic title of Professor of Surgery. The department grew from five to 20 members in just five years, and Dr. Ouriel was promoted to the position of Chief of Surgery in 2003. A total of 14 Departments including Cardiothoracic Surgery, Urology, Orthopedics, Dentistry, Ob/Gyn, Plastic Surgery, ENT, Vascular Surgery, and the Center for Surgical Research reported to Dr. Ouriel, comprising 340 attending surgeons and 2500 FTE. Dr. Ouriel was a member of the Clinic's Executive Team, the committee of C-level individuals and the Chiefs of Medicine and Surgery, presiding over the Cleveland Clinic Health System. Dr. Ouriel was a member of the Executive Committee of the Society of Vascular Surgery, serving as that society's recorder between 2003 and 2006. He is the author of 3 textbooks in vascular surgery and over 250 original scientific articles on a wide variety of vascular surgical topics but focusing on minimally invasive means to treat vascular disease. He was the principal investigator on a five-year, $5M NIH grant on intravascular ultrasound and the atherosclerotic plaque, funded at $1M/yr for 5 years (2003 - 2008).

In 2007, Dr. Ouriel accepted the role of CEO for the Clinic's Abu Dhabi project; running a 750 bed, 4-hospital system, the Sheikh Khalifa Medical City - the flagship hospital and Level I trauma center for the Emirate of Abu Dhabi, with 5000 FTE and 700 physicians. Dr. Ouriel recruited 12 US leaders to the hospital, all but one from the Cleveland Clinic, to join him in the management of the facility. He fostered the development of a new renal transplantation program and the first kidney transplant was performed in early 2008. In April of 2008 the hospital underwent its first Joint Commission International survey and was fully accredited by that organization. At this time, Dr. Ouriel enrolled in the Columbia/London Business School Global Executive MBA program, the course work of which will be completed during the summer of this year.

In June, 2008, after living in Abu Dhabi for one year, Dr. Ouriel accepted the position of Senior Vice President and Chief of International Operations at NewYork-Presbyterian.


	Back to Top